Endolimax nana and urticaria

Stefano Veraldi; Luisa Angileri; Luisa Carlotta Rossi; Gianluca Nazzaro

doi:10.3855/jidc.12389

Endolimax nana and urticaria

Authors

Stefano Veraldi Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Foundation I.R.C.C.S., Cà Granda Ospedale Maggiore Policlinico, Milan, Italy
Luisa Angileri Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Foundation I.R.C.C.S., Cà Granda Ospedale Maggiore Policlinico, Milan, Italy
Luisa Carlotta Rossi Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Foundation I.R.C.C.S., Cà Granda Ospedale Maggiore Policlinico, Milan, Italy
Gianluca Nazzaro Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Foundation I.R.C.C.S., Cà Granda Ospedale Maggiore Policlinico, Milan, Italy

DOI:

https://doi.org/10.3855/jidc.12389

Keywords:

abdominal pain, chronic urticaria, diarrhoea, Endolimax nana, metronidazole, weight loss

Abstract

Endolimax nana is a commensal protozoan of the colon. We report a case of chronic urticaria associated with E. nana in a 34-year-old Italian woman. The patient suffered from abdominal pain, diarrhoea and weight loss. The disease appeared after a trip to Vietnam. Laboratory examinations showed mild blood eosinophilia. Three coproparasitological examinations were positive for cysts of E. nana. The patient was successfully treated with two courses of metronidazole (2 g/day for 10 days each). No antihistamines were used. Three coproparasitological examinations, carried out at the end of the therapy, were negative. Follow up (six months) was negative. E. nana can be responsible for very rare cases of abdominal pain, diarrhoea, polyarthritis and urticaria.

Downloads

Published

2020-03-31

How to Cite

Veraldi S, Angileri L, Rossi LC, Nazzaro G (2020) Endolimax nana and urticaria. J Infect Dev Ctries 14:321–322. doi: 10.3855/jidc.12389

Download Citation

Endnote/Zotero/Mendeley (RIS)

Issue

Vol. 14 No. 03: March 2020

Section

Case Reports

License

Authors who publish with this journal agree to the following terms:

Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).